On average, patients taking semaglutide 2.4 mg (Wegovy) lose approximately 15% of their body weight over 68 weeks, according to the landmark STEP 1 clinical trial . For a person weighing 250 pounds, that translates to roughly 37 pounds. Individual results vary widely, with some patients losing over 20% of their body weight and others losing closer to 10%, depending on factors like starting weight, diet, exercise habits, and medication adherence.

What the Clinical Trials Show

The STEP trial series provides the most robust data on semaglutide weight loss outcomes:

• STEP 1: Average weight loss of 14.9% over 68 weeks. About one-third of participants lost 20% or more of their body weight .
• STEP 2 (diabetes patients): Average weight loss of 9.6%, which is lower due to the metabolic challenges of type 2 diabetes .
• STEP 3 (with intensive behavioral therapy): Average weight loss of 16%, showing the benefit of combining medication with structured lifestyle changes .
• STEP 5 (2-year data): Weight loss was maintained and slightly improved at 104 weeks, averaging about 15.2% .

These results are significantly better than lifestyle changes alone, which typically produce 2-5% weight loss in clinical settings .

Real-World Results vs. Clinical Trials

Real-world weight loss on semaglutide can differ from clinical trial results. Some studies of real-world patients show slightly lower average weight loss of 10-12%, which is common when comparing controlled trial settings to everyday use . Factors that contribute to this gap include:

• Less structured dietary and exercise support
• Variable medication adherence
• Differences in dosing schedules
• Insurance or cost barriers leading to interruptions

That said, even 10% body weight loss is clinically meaningful and associated with significant improvements in blood pressure, blood sugar, cholesterol, and joint pain .

Factors That Influence Your Results

Starting Weight

Patients with higher starting weights tend to lose more absolute weight (in pounds) but may lose a similar or slightly lower percentage of body weight compared to those starting at a lower weight.

Diet and Nutrition

Semaglutide reduces appetite, but food choices still matter. A diet focused on lean protein, vegetables, and whole foods tends to maximize results. Avoiding high-fat, high-sugar foods helps minimize GI side effects and supports better outcomes foods to avoid on GLP-1.

Exercise

Adding regular physical activity, especially resistance training, can improve weight loss results and help preserve lean muscle mass exercise on GLP-1. The STEP 3 trial showed that combining semaglutide with intensive behavioral therapy (which included exercise guidance) improved outcomes by about 1 percentage point.

Dose

Higher doses of semaglutide generally produce greater weight loss. The maximum approved dose for weight management is 2.4 mg weekly. Patients who cannot tolerate this dose may stay on a lower dose with somewhat less weight loss .

Weight Loss Timeline

Weight loss on semaglutide follows a predictable pattern:

• Weeks 1-4: Appetite reduction begins. Weight loss of 2-5 pounds is common during the initial low dose period.
• Months 1-4: As the dose increases, weight loss accelerates. Most patients lose 5-10% of body weight by month 4.
• Months 4-12: The fastest rate of weight loss typically occurs during this phase.
• Months 12-18: Weight loss gradually plateaus as the body reaches a new equilibrium how fast does semaglutide work.

Frequently Asked Questions